摘要
目的探讨乳腺亚临床病灶的性质及Encor微创旋切术对其的诊治价值。方法对630例964个乳腺亚临床病灶行B超引导下Encor微创旋切术,分析术后病理诊断结果。结果 964个亚临床病灶成功切除。术后病理示纤维腺瘤686个(71.2%),囊肿132个(13.7%),乳管内乳头状瘤45个(4.7%),腺病瘤89个(9.2%),乳腺癌12个(1.2%)。136个BI-RADSⅣ级病灶中3个确诊为乳腺癌;而BI-RADSⅡ～Ⅲ级中,9个病灶术后病理诊断为乳腺癌,漏诊率为1.09%(9/828)。良性病例随访至今,定期复查超声及乳腺钼靶X线摄片未见复发及恶性病变出现。结论 B超诊断的良性乳腺亚临床病灶中仍有漏诊乳腺癌可能,需要密切随访。辅助Encor活检对亚临床病灶的切检效果准确、可靠,是"一步手术"诊治的最佳选择,可降低早期乳腺癌漏诊的风险。
Objective To determine the pathology of subclinical breast mass and evaluate the diagnostic value of the US-gnided encor biopsy. Methods B-ultrasound-guided minimally invasive encor biopsy system was performed for 964 nonpalpable breast lesions of 630 patients. Results 964 subclinical breast masses were operaled succesfully. Of the 630 patients with 964 encor biopsies ,686 were diagnosed as broadenomas（7l. 2% ） , 132 were diagnosed as cysts（ 13.7% ） ,45 were diagnosed as intraductal apillomas（4.7% ）,89 were diagnosed as adeacsis （9.2%） ,and 12 were diagnosed as early breast cancers（ 1.2% ）. 3 lesions were diagnosed as breast cancer in 136 BI-RADS IV lesions. 9 lesions were diagnosed as breast cancer in 828 BI-RADS IV lesions. The omission diagnostic rate for breast cancer was 1.09% （9/828）. These patients had no positive finding by follow-up. Con- ~lusions A small percentage of diagnosing benign breast subclinical lesions by mammography and sonography also maybe be malignancy. Close follow-up is necessary. The Encor biopsy technique is effective, microinvasived, and rapid diagnostic and excised tool for ＂one-step operation ＂of breast subclinical masses.
出处
《中国肿瘤外科杂志》
CAS
2013年第3期165-167,共3页
Chinese Journal of Surgical Oncology
基金
韶关市医药卫生科研计划项目(No.Y11020)
